Allianz Asset Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-1,150,306
| Closed | -$20.7M | – | 2502 |
|
|
2020
Q2 | $20.7M | Buy |
+1,150,306
| New | +$16M | 0.02% | 604 |
|
|
2019
Q2 | – | Sell |
-41,937
| Closed | -$1.46M | – | 2813 |
|
|
2019
Q1 | $1.46M | Buy |
+41,937
| New | +$1.21M | ﹤0.01% | 1958 |
|
|
2018
Q4 | – | Sell |
-51,970
| Closed | -$1.38M | – | 2754 |
|
|
2018
Q3 | $1.38M | Sell |
51,970
-24,250
| -32% | -$792K | ﹤0.01% | 2095 |
|
|
2018
Q2 | $2.88M | Sell |
76,220
-95,545
| -56% | -$3.65M | ﹤0.01% | 1785 |
|
|
2018
Q1 | $5.61M | Sell |
171,765
-59,598
| -26% | -$2.62M | 0.01% | 1487 |
|
|
2017
Q4 | $11.3M | Sell |
231,363
-1,740
| -0.7% | -$88K | 0.01% | 1266 |
|
|
2017
Q3 | $12.6M | Buy |
233,103
+7,763
| +3% | +$456K | 0.01% | 1208 |
|
|
2017
Q2 | $12.7M | Sell |
225,340
-22,925
| -9% | -$918K | 0.01% | 1199 |
|
|
2017
Q1 | $9.71M | Buy |
248,265
+231,645
| +1,394% | +$7.38M | 0.01% | 1349 |
|
|
2016
Q4 | $373K | Hold |
16,620
| – | – | ﹤0.01% | 2423 |
|
|
2016
Q3 | $377K | Sell |
16,620
-380
| -2% | -$8.92K | ﹤0.01% | 2403 |
|
|
2016
Q2 | $401K | Buy |
+17,000
| New | +$420K | ﹤0.01% | 2360 |
|
|
2016
Q1 | – | Sell |
-39,800
| Closed | -$2.05M | – | 2629 |
|
|
2015
Q4 | $2.05M | Hold |
39,800
| – | – | ﹤0.01% | 1696 |
|
|
2015
Q3 | $1.7M | Hold |
39,800
| – | – | ﹤0.01% | 1645 |
|
|
2015
Q2 | $1.81M | Buy |
+39,800
| New | +$1.6M | ﹤0.01% | 1741 |
|
Allianz Asset Management's PTLA Position: Q3 2020 in Review
Allianz Asset Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 1,150,306 shares — an estimated $20.7M sold.
Allianz Asset Management first reported a position in PTLA in Q2 2015 and held it in 15 quarters. The position peaked at $20.7M in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- Allianz Asset Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Allianz Asset Management sold 1,150,306 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $20.7M.
- Allianz Asset Management first reported a position in Portola Pharmaceuticals, Inc. in Q2 2015 and held it in 15 quarters.
- Allianz Asset Management's Portola Pharmaceuticals, Inc. position peaked at $20.7M in Q2 2020.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on Allianz Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.